Clinical Trial Update: Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial is investigating Huperzine A sustained-release tablets for Alzheimer's disease in Phase 2 and Phase 3. The current status of the trial is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Huperzine A Sustained-Release Tablets (Huperzine A)

Snippet

Sponsor: Shandong Luye Pharmaceutical Co., Ltd. | Conditions: Alzheimer's Disease | Phase 2, Phase 3 | Status: UNKNOWN